<?xml version='1.0'?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:georss="http://www.georss.org/georss" xmlns:atom="http://www.w3.org/2005/Atom" >
<channel>
	<title><![CDATA[BOL: Related items]]></title>
	<link>https://bioinformaticsonline.com/related/29614?offset=250</link>
	<atom:link href="https://bioinformaticsonline.com/related/29614?offset=250" rel="self" type="application/rss+xml" />
	<description><![CDATA[]]></description>
	
	<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/bookmarks/view/44373/mitohifi-a-python-pipeline-for-mitochondrial-genome-assembly-from-pacbio-high-fidelity-reads</guid>
	<pubDate>Tue, 05 Sep 2023 07:31:35 -0500</pubDate>
	<link>https://bioinformaticsonline.com/bookmarks/view/44373/mitohifi-a-python-pipeline-for-mitochondrial-genome-assembly-from-pacbio-high-fidelity-reads</link>
	<title><![CDATA[MitoHiFi: a python pipeline for mitochondrial genome assembly from PacBio high fidelity reads]]></title>
	<description><![CDATA[<p dir="auto">MitoHiFi v3.2 is a python pipeline distributed under&nbsp;<a href="https://github.com/marcelauliano/MitoHiFi/blob/master/LICENSE">MIT License</a>&nbsp;!</p>
<p dir="auto">MitoHiFi was first developed to assemble the mitogenomes for a wide range of species in the Darwin Tree of Life Project (DToL)</p>
<p dir="auto">https://bmcbioinformatics.biomedcentral.com/articles/10.1186/s12859-023-05385-y&nbsp;</p>
<p dir="auto"><a href="https://github.com/marcelauliano/MitoHiFi/blob/master/docs/dtol-logo-round-300x132.png" target="_blank"><img src="https://github.com/marcelauliano/MitoHiFi/raw/master/docs/dtol-logo-round-300x132.png" alt="" style="border: 0px; border: 0px;"></a></p><p>Address of the bookmark: <a href="https://github.com/marcelauliano/MitoHiFi" rel="nofollow">https://github.com/marcelauliano/MitoHiFi</a></p>]]></description>
	<dc:creator>Abhi</dc:creator>
</item>

<item>
  <guid isPermaLink='true'>https://bioinformaticsonline.com/opportunity/view/19690/bioinformatics-scientist-at-icar-labs</guid>
  <pubDate>Sun, 21 Dec 2014 23:47:03 -0600</pubDate>
  <link></link>
  <title><![CDATA[Bioinformatics Scientist at ICAR Labs]]></title>
  <description><![CDATA[
<p>AGRICUL AGRICULTURAL SCIENTISTS RECRUITMENT BOARD TURAL SCIENTISTS RECRUITMENT BOARD<br />KRISHI ANUSANDHAN BHAVAN-I, PUSA, NEW DELHI-110 012</p>

<p>ADVERTISEMENT NO. 03/2014</p>

<p>PRINCIPAL SCIENTIST</p>

<p>Pay Band: Minimum pay of `43,000 in the PB-4 of `37400-67000/- + RGP of `10,000/-.</p>

<p>Age: The candidates must not have attained the age of 52 years as on 19.01.2015. There shall be no age limit for the Council’s employees.</p>

<p>ICAR-Indian Institute for Agricultural Biotechnology, (IIAB) Ranchi (Jharkhand)</p>

<p>151. Principal Scientist (Bioinformatics) (One post)</p>

<p>SENIOR SCIENTIST/PROGRAMME COORDINATOR</p>

<p>Pay Band: PB-4 of ` 37400-67000/- + RGP of ` 9,000/-.</p>

<p>Age: The candidates must not have attained the age of 47 years as on 19.01.2015. There shall be no age limit for the Council’s employees.</p>

<p>National Institute of Biotic Stress Management, Raipur (Chhattishgarh)</p>

<p>166. Senior Scientist (Bioinformatics) (One post)</p>

<p>IMPORTANT NOTE<br />I. (i) CLOSING DATE</p>

<p>THE CLOSING DATE FOR RECEIPT OF APPLICATIONS IN AGRICULTURAL SCIENTISTS RECRUITMENT BOARD IS 19.01.2015 (For applications posted from abroad and in the Andaman and Nicobar Islands, Lakshdweep, Minicoy and Amindivi islands, States/ Union Territories in the North-Eastern Region, Ladakh Division of J &amp; K State, Sikkim, Pangi, Sub-division of Chamba, Lahul and Spiti Districts of Himachal Pradesh, the last date for receipt of application will be 02.02.2015). Non receipt of the application by the closing date will result in rejection of the application.</p>

<p>More Info: http://asrb.org.in/administrator/uploads_dir/1418978057english.pdf</p>
]]></description>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/bookmarks/view/35055/jabba-hybrid-error-correction-for-long-sequencing-reads</guid>
	<pubDate>Fri, 05 Jan 2018 03:58:14 -0600</pubDate>
	<link>https://bioinformaticsonline.com/bookmarks/view/35055/jabba-hybrid-error-correction-for-long-sequencing-reads</link>
	<title><![CDATA[Jabba: Hybrid Error Correction for Long Sequencing Reads]]></title>
	<description><![CDATA[<p>Jabba is a hybrid error correction tool to correct third generation (PacBio / ONT) sequencing data, using second generation (Illumina) data.</p>
<p>Input</p>
<p>Jabba takes as input a concatenated de Bruijn graph and a set of sequences:</p>
<p>the de Bruijn graph should appear in fasta format with 1 entry per node, the meta information should be in the format:<br>&gt;NODE <br>the set of sequences should be in fasta or fastq format. These sequences will be corrected (e.g. PacBio reads). The corrections will be written to a file Jabba fasta.<br>The output is a file in fasta format with corrections of the long reads, and additionally a file in the input format containing uncorrected reads.</p>
<p>https://github.com/biointec/jabba/wiki</p>
<p>https://almob.biomedcentral.com/articles/10.1186/s13015-016-0075-7</p><p>Address of the bookmark: <a href="https://github.com/biointec/jabba" rel="nofollow">https://github.com/biointec/jabba</a></p>]]></description>
	<dc:creator>Jit</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/bookmarks/view/19786/shrec3d</guid>
	<pubDate>Thu, 25 Dec 2014 23:14:52 -0600</pubDate>
	<link>https://bioinformaticsonline.com/bookmarks/view/19786/shrec3d</link>
	<title><![CDATA[ShRec3D]]></title>
	<description><![CDATA[<p><strong>ShRec3D</strong> is a program that aims at reconstructing a genome 3D structure (b) from the sole knowledge of the contacts between different genomic regions (a) as determined by Hi-C (http://www.ncbi.nlm.nih.gov/pubmed/19815776).</p>
<p>There are two options to run ShRec3D (on linuX only so far): the first one uses the Matlab complier runtime environment (MCR), the second one doesn't need any other library to be installed but only works with the latest versions of Linux (equivalent to Fedora 19 and above).</p><p>Address of the bookmark: <a href="https://sites.google.com/site/julienmozziconacci/#TOC-Downloads" rel="nofollow">https://sites.google.com/site/julienmozziconacci/#TOC-Downloads</a></p>]]></description>
	<dc:creator>Jitendra Narayan</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/bookmarks/view/40893/quorum-an-error-corrector-for-illumina-reads</guid>
	<pubDate>Tue, 04 Feb 2020 23:26:55 -0600</pubDate>
	<link>https://bioinformaticsonline.com/bookmarks/view/40893/quorum-an-error-corrector-for-illumina-reads</link>
	<title><![CDATA[QuorUM: An Error Corrector for Illumina Reads]]></title>
	<description><![CDATA[<p><span>We produce trimmed and error-corrected reads that result in assemblies with longer contigs and fewer errors. We compared QuorUM against several published error correctors and found that it is the best performer in most metrics we use. QuorUM is efficiently implemented making use of current multi-core computing architectures and it is suitable for large data sets (1 billion bases checked and corrected per day per core)</span></p><p>Address of the bookmark: <a href="http://www.genome.umd.edu/" rel="nofollow">http://www.genome.umd.edu/</a></p>]]></description>
	<dc:creator>BioStar</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/poll/view/19921/which-of-the-followings-are-the-best-place-to-study-bioinformatics</guid>
	<pubDate>Sun, 28 Dec 2014 00:20:30 -0600</pubDate>
	<link>https://bioinformaticsonline.com/poll/view/19921/which-of-the-followings-are-the-best-place-to-study-bioinformatics</link>
	<title><![CDATA[Which of the followings are the best place to study Bioinformatics ?]]></title>
	<description><![CDATA[<p>Bioinformatics is a major growth area and qualified Bioinformaticians are in high demand. An explosion in biological data has resulted from genome projects, next generation sequencing and other 'omics' techniques. Bioinformatics provides the tools to analyse and exploit such data sets.<br /><br />Can you please suggest me the best place to study bioinformatics ( Grad/PostGrad).</p>]]></description>
	<dc:creator>Reshma Khatun</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/blog/view/44848/trust-but-verify-sequencing-your-cell-lines-might-reveal-an-uninvited-guest</guid>
	<pubDate>Wed, 04 Jun 2025 00:07:57 -0500</pubDate>
	<link>https://bioinformaticsonline.com/blog/view/44848/trust-but-verify-sequencing-your-cell-lines-might-reveal-an-uninvited-guest</link>
	<title><![CDATA[Trust But Verify: Sequencing Your Cell Lines Might Reveal an Uninvited Guest]]></title>
	<description><![CDATA[<p>High-throughput sequencing has become indispensable in cell biology, enabling detailed insights into chromatin structure, gene expression, and regulatory dynamics. Yet, when faced with unexpectedly low mapping rates to the human genome, researchers often rush to troubleshoot technical parameters&mdash;sequencer quality, adapter trimming, or aligner settings.</p><p>Before you go down that path, consider this critical biological question:<br /> <strong>Are you sequencing human cells&mdash;or bacterial contamination?</strong></p><h2>The Silent Saboteur: Mycoplasma in Cell Cultures</h2><p><em>Mycoplasma</em> contamination remains one of the most widespread and underdiagnosed issues in tissue culture work. Studies suggest that <strong>15&ndash;35% of cell lines in use may be contaminated</strong>, often without visible signs. Unlike other microbial infections, <em>Mycoplasma</em> does not produce cloudiness, odor, or a change in pH. Many researchers won&rsquo;t detect it unless they specifically test for it.</p><p>The consequences, however, are profound. <em>Mycoplasma</em> can significantly alter:</p><ul>
<li>
<p>Host gene expression patterns</p>
</li>
<li>
<p>Cell proliferation rates</p>
</li>
<li>
<p>Epigenetic profiles and chromatin accessibility</p>
</li>
<li>
<p>Cytokine signaling and immune responses</p>
</li>
</ul><p>In short, it can skew your results, compromise your biological conclusions, and invalidate weeks or months of research.</p><h2>A Simple Diagnostic Step: Map Against <em>Mycoplasma</em> Genomes</h2><p>If you encounter poor alignment rates to the human genome, consider mapping your reads to a <em>Mycoplasma</em> reference genome&mdash;or better yet, use a <strong>combined human + <em>Mycoplasma</em></strong> reference. There have been cases where over half of all reads, initially assumed to be from human cells, were in fact bacterial in origin. This check is fast, easy, and could save your project.</p><h2>How Contamination Happens&mdash;and Persists</h2><p><em>Mycoplasma</em> is small (0.1&ndash;0.3 &mu;m), lacks a cell wall, and can pass through standard filters undetected. Common sources include:</p><ul>
<li>
<p>Contaminated reagents (e.g., FBS)</p>
</li>
<li>
<p>Infected cell lines obtained from other labs</p>
</li>
<li>
<p>Poor aseptic technique or shared equipment</p>
</li>
</ul><p>Once present, it spreads quickly between cultures and can persist for months, silently affecting results.</p><h2>Why Treatment Is Difficult</h2><p>While antibiotics such as Plasmocin or BM-Cyclin are sometimes used, they often offer only partial resolution and may themselves alter cell behavior. In many cases, the best course of action is to <strong>discard the contaminated culture</strong> and start with a fresh, verified stock.</p><h2>Practical Recommendations for Researchers</h2><ul>
<li>
<p><strong>Routinely test for <em>Mycoplasma</em></strong> using PCR, qPCR, or fluorescence-based assays</p>
</li>
<li>
<p><strong>Incorporate contamination screens into your sequencing QC pipeline</strong></p>
</li>
<li>
<p><strong>Use combined reference genomes</strong> when mapping ambiguous reads</p>
</li>
<li>
<p><strong>Practice strict aseptic technique</strong> and monitor all incoming cell lines</p>
</li>
<li>
<p><strong>Don&rsquo;t ignore unexplained data anomalies</strong>&mdash;they might point to contamination</p>
</li>
</ul><h2>Closing Thought: Contamination Is a Biological Variable</h2><p>It&rsquo;s easy to view poor mapping as a technical issue, but sometimes the problem lies deeper&mdash;in the biology itself. <em>Mycoplasma</em> contamination doesn&rsquo;t just interfere with sequencing; it interferes with science. As a research community, we must treat contamination not as an afterthought, but as a key variable to control.</p><p>So next time your reads won&rsquo;t align, don&rsquo;t just tune the aligner. Ask if your cells are telling the truth&mdash;or if they're hiding something.</p>]]></description>
	<dc:creator>LEGE</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/news/view/20007/roche-has-acquired-bina-technologies</guid>
	<pubDate>Tue, 30 Dec 2014 09:42:16 -0600</pubDate>
	<link>https://bioinformaticsonline.com/news/view/20007/roche-has-acquired-bina-technologies</link>
	<title><![CDATA[Roche has acquired Bina Technologies !!!]]></title>
	<description><![CDATA[<p>Bina Technologies is a privately held company that provides a big data platform for centralized management and processing of next generation sequencing (NGS) data for the academic and translational research markets.&nbsp; Bina will be integrated into the Roche Sequencing Unit, and will continue to focus on development of their innovative genomic analysis solution.<br /><br />Roche has acquired Bina Technologies, a privately-owned biotech company based in California. The biotech&rsquo;s first product was the Bina Box, a platform for secondary genomic analysis, sequence alignment, and variant calling, but since 2012, it has developed other products and platforms. <br /><br />It is our shared vision with Roche that informatics and data sciences are critical elements of an end-to-end genomics solution. Fast, easy-to-use, scalable, and robust informatics solutions make a big difference in the quality and impact of the work of scientists and researchers. We believe in the future of data-driven, personalized medicine. We are passionate about accelerating that future together with Roche.<br /><br />Financial details of the deal were not disclosed. For Roche, the move is yet another in a string of acquisitions. Last week (December 18), Roche paid $489 million for antibody maker Dutalys. And earlier this month, Roche bought prenatal testing company Ariosa Diagnostics.</p><p>Reference</p><p>http://blog.bina.com/news/bina-technologies-acquired-by-roche?&amp;__hssc=109677338.1.1419953400266&amp;__hstc=109677338.b8350f2729889b08f1325906d5236cd3.1419953400266.1419953400266.1419953400266.1&amp;hsCtaTracking=96cac941-9372-4bbf-bacb-3ca6f1ff8cfd|3fce0f18-835b-4086-9345-388880861732</p><p>http://www.the-scientist.com/?articles.view/articleNo/41750/title/Roche-Buys-Bioinformatics-Firm/</p>]]></description>
	<dc:creator>Jit</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/bookmarks/view/34704/nanosim-nanopore-sequence-read-simulator-based-on-statistical-characterization</guid>
	<pubDate>Mon, 18 Dec 2017 04:16:31 -0600</pubDate>
	<link>https://bioinformaticsonline.com/bookmarks/view/34704/nanosim-nanopore-sequence-read-simulator-based-on-statistical-characterization</link>
	<title><![CDATA[NanoSim: nanopore sequence read simulator based on statistical characterization.]]></title>
	<description><![CDATA[<p><span>NanoSim, a fast and scalable read simulator that captures the technology-specific features of ONT data and allows for adjustments upon improvement of nanopore sequencing technology. The first step of NanoSim is read characterization, which provides a comprehensive alignment-based analysis and generates a set of read profiles serving as the input to the next step, the simulation stage. The simulation stage uses the model built in the previous step to produce in silico reads for a given reference genome. NanoSim is written in Python and R. The source files and manual are available at the Genome Sciences Centre website: http://www.bcgsc.ca/platform/bioinfo/software/nanosim</span></p>
<p><span>https://github.com/bcgsc/NanoSim</span></p><p>Address of the bookmark: <a href="http://www.bcgsc.ca/platform/bioinfo/software/nanosim" rel="nofollow">http://www.bcgsc.ca/platform/bioinfo/software/nanosim</a></p>]]></description>
	<dc:creator>Jit</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/news/view/20331/type-hinting</guid>
	<pubDate>Fri, 09 Jan 2015 22:26:13 -0600</pubDate>
	<link>https://bioinformaticsonline.com/news/view/20331/type-hinting</link>
	<title><![CDATA[Type Hinting]]></title>
	<description><![CDATA[<p>Python creator Guido van Rossum&rsquo;s proposal for static type-checking annotations is inching closer to reality, and the feature has taken on a new name: type hinting.</p><p><img src="http://sdtimes.com/wp-content/uploads/2015/01/0107.sdt-python-typehinting.png" alt="image" width="619" height="219" style="border: 0px; border: 0px;"></p><p>Back in August, van Rossum published a proposal on the Python mailing list recommending type-checking annotations as a valuable feature for the next version of Python to improve the performance of editors and IDEs, linter capabilities, standard notation, and refactoring. Van Rossum&rsquo;s <a href="http://lwn.net/Articles/627558/">latest proposal</a>, posted late last month, outlined plans to publish a Python Enhancement Proposal (PEP) in early January to put the feature now known as type hinting on track for inclusion in Python 3.5, slated for release this September.</p><p>Reference</p><p>https://quip.com/r69HA9GhGa7J</p>]]></description>
	<dc:creator>Pranjali Yadav</dc:creator>
</item>

</channel>
</rss>